路德生物环保科技股份有限公司 证券代码：688156 证券简称：路德环境 公告编号：2025-028 路德生物环保科技股份有限公司 关于董事会完成换届选举及聘任高级管理人员、证券事务代 表的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 路德生物环保科技股份有限公司（以下简称"公司"）于 2025 年 5 月 12 日召开了 2024 年年度股东大会，选举产生了公司第五届董事会非独立董事 3 名、 独立董事 3 名。上述人员与公司职工代表大会选举产生的职工代表董事 1 名，共 同组成了公司第五届董事会。同日，公司召开第五届董事会第一次会议，选举产 生了公司董事长、董事会专门委员会委员，并聘任了公司新一届高级管理人员和 证券事务代表。现将相关情况公告如下： 一、董事会换届选举情况 （一）董事选举情况 2025 年 5 月 12 日，公司召开 2024 年年度股东大会，本次股东大会采用累 积投票制的方式选举季光明先生、季维宽先生、沈水宝先生担任第五届董事会非 独立董事，选举史永先生、陈雄先生、蒋天文先生担任第五届董事会独 ...

证券代码：688156 证券简称：路德环境 公告编号：2025-029 路德生物环保科技股份有限公司 2025 年 5 月 13 日 1 路德生物环保科技股份有限公司 附件：职工代表董事简历 路德生物环保科技股份有限公司 关于选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《中华人民共和国公司法》《上海证券交易所科创板上市公司自律监管 指引第 1 号—规范运作》及《公司章程》等相关规定，路德生物环保科技股份有 限公司（以下简称"公司"）于 2025 年 5 月 12 日召开了职工代表大会，经与会 职工代表认真审议及民主选举，一致同意选举郑应家先生为公司第五届董事会职 工代表董事（简历详见附件），与 2024 年年度股东大会选举产生的 6 名非职工 代表董事共同组成第五届董事会，任期与第五届董事会任期一致，自 2024 年年 度股东大会审议通过非职工代表董事之日起三年。 郑应家先生任职资格符合相关法律、行政法规、部门规章、规范性文件等对 董事的任职资格要求，不存在《公司法》《公司章程》规定的不得担 ...

Hill TAHO' 泰和泰 泰和泰（武汉）律师事务所 关于路德生物环保科技股份有限公司 2024年年度股东会 之 法律意见书 二〇二五年五月十二日 三 法律意见书 泰和泰 (武汉)律师事务所 关于路德生物环保科技股份有限公司 2024年年度股东会 之 法律意见书 致:路德生物环保科技股份有限公司 泰和泰(武汉)律师事务所(以下简称"泰和泰""本所"或)作为路德生 物环保科技股份有限公司(以下简称"路德环境""公司")的常年法律顾问, 受公司委托,指派秦为径、邱亚飞律师出席公司 2024年年度股东会（以下简称 "本次股东会"),并依据《中华人民共和国公司法》(以下简称"《公司法》")、 中国证券监督管理委员会《上市公司股东会规则》(以下简称"《股东会规则》")、 公司现行章程及其他相关法律、法规的规定,就本次股东会的召集召开程序、召 集人的资格、出席和列席本次股东会人员的资格、会议的表决程序等有关事宜进 行见证,并出具本法律意见书。 公司已向本所保证,已向本所提供了为出具本法律意见书所必需的材料,所 提供的原始材料、副本、复印件、口头语言等均符合真实、准确、完整的要求, 有关副本、复印件等材料与原始材料一致。 ...

证券代码：688156 证券简称：路德环境 公告编号：2025-026 路德生物环保科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 05 月 12 日 （二） 股东大会召开的地点：武汉市东湖新技术开发区未来科技城九龙湖街 51 号（路德环境） （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 23 | | --- | --- | | 普通股股东人数 | 23 | | 2、出席会议的股东所持有的表决权数量 | 30,096,732 | | 普通股股东所持有表决权数量 | 30,096,732 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 29.8833 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 29.8833 ...

路德生物环保科技股份有限公司 证券代码：688156 证券简称：路德环境 公告编号：2025-027 路德生物环保科技股份有限公司 第五届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 路德生物环保科技股份有限公司（以下简称"公司"）第五届董事会第一次 会议于 2025 年 5 月 12 日在公司会议室以现场与通讯表决相结合的方式召开，本 次会议于公司 2024 年年度股东大会结束后，口头通知公司第五届董事会全体当选 董事参加会议，经全体董事同意，豁免了本次会议通知关于时限的要求。本次会 议应出席董事 7 名，实到 7 名，经与会董事一致推举，本次会议由董事季光明先 生主持。会议的召集、召开和表决情况符合《中华人民共和国公司法》（以下简 称"《公司法》"）等有关法律、法规及《路德生物环保科技股份有限公司章程》 （以下简称"公司章程"）的规定，形成的决议合法、有效。 二、董事会会议审议情况 参会董事逐项审议并以投票表决方式通过了下列议案： （一）审议通过《关于豁免本次董事会通 ...

Core Viewpoint - The company, Lude Environment, focuses on the resource utilization of brewing by-products through synthetic biology, aiming to expand its applications into food ingredients, bio-based materials, and cosmetics by 2025 [1][5]. Group 1: Company Overview - Lude Environment was established in 2006 and utilizes synthetic biology as a foundational technology, focusing on brewing by-products as a substrate for microbial production [3]. - The company has developed a comprehensive biomanufacturing technology chain, including strain selection, fermentation control, and product enrichment, positioning itself as a leader in industrial applications [3]. Group 2: Current Projects and Achievements - As of the end of 2024, Lude Environment has five operational factories with an annual production capacity of 470,000 tons, and plans to increase total capacity to 700,000 tons [4]. - The company has made significant progress in its research project on producing gamma-aminobutyric acid (GABA) from brewing waste, achieving a 200L fermentation pilot scale and publishing two SCI papers [1][4]. Group 3: Future Development Plans - Lude Environment plans to establish a "synthetic biology pilot platform" by 2025, focusing on next-generation core technology reserves through independent research and industry-academia collaboration [5]. - The company aims to enhance its R&D efforts to introduce new high-value bioactive molecules and diversify its business into new application areas such as bio-materials, cosmetics, and health foods [5].

路德生物环保科技股份有限公司 2024 年年度股东大会会议资料 路德生物环保科技股份有限公司 2024 年年度股东大会 会议资料 股票代码：688156 股票简称：路德环境 二零二五年五月 1 路德生物环保科技股份有限公司 2024 年年度股东大会会议资料 路德生物环保科技股份有限公司 2024 年年度股东大会会议资料 路德生物环保科技股份有限公司 2024 年年度股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证 大会的顺利进行，根据《中华人民共和国公司法》《中华人民共和国证券法》、 中国证监会《上市公司股东会规则》以及《路德生物环保科技股份有限公司章程》 《路德生物环保科技股份有限公司股东大会议事规则》的相关规定，特制定 2024 年年度股东大会会议须知： 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、为保证股东大会的严肃性和正常秩序，切实维护与会股东（或股东代理 人）的合法权益，除出席会议的股东（或股东代理人）、公司董事、监事、高级 管理人员、见证律师及董事会邀请的人员外，公司有 ...

Core Viewpoint - The company's revenue decline is primarily due to the contraction of its inorganic solid waste business, while losses are impacted by decreased feed gross margins and increased expenses, although operating cash flow has significantly improved [2] Group 1: Financial Performance - In 2024, the company achieved operating revenue of 278 million, a year-on-year decrease of 21% [1] - The net profit attributable to shareholders was -57 million, a year-on-year decrease of 310% [1] - In Q1 2025, the company reported operating revenue of 63 million, a year-on-year decline of 7% [1] - The net profit attributable to shareholders for Q1 2025 was 1 million, a year-on-year decrease of 78% [1] Group 2: Business Segment Analysis - The biological fermentation feed business generated revenue of 217 million, a year-on-year increase of 10.19%, with sales volume rising to 112,600 tons, a 21% increase [3] - The gross margin for the biological feed business decreased by 7.76 percentage points to 22.04% due to price reductions and high-cost raw material inventory [3] - The inorganic solid waste treatment service business reported revenue of 41.19 million, a year-on-year decline of 72% [4] - The company has initiated a project in Lianyungang with a contract value of approximately 600 million, expected to contribute incremental revenue to the inorganic solid waste segment [4] Group 3: Capacity Expansion - The company has successfully launched new production capacities, with total production capacity reaching 470,000 tons per year [3] - Ongoing projects include the Suqian Road De (140,000 tons/year) and Xiangxi Road Kangde (40,000 tons/year), with a total planned capacity of 700,000 tons per year [3] Group 4: Profit Forecast - The company is projected to achieve operating revenues of 400 million, 609 million, and 821 million for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 44.24%, 52.03%, and 34.81% [4] - The net profit attributable to shareholders is expected to be 3 million, 12 million, and 20 million for the same years, with significant growth rates of 104.95%, 329.42%, and 145.62% [4]

Group 1: Company Research - Lude Environment's main business includes river and lake sludge treatment services, engineering mud treatment services, industrial residue resource sales, and environmental technology equipment sales. The company is working on a project involving synthetic biology technology to produce GABA from waste fermentation products [1] - Zhongchong Co., Ltd. reported a revenue of 1.101 billion yuan for Q1 2025, a year-on-year increase of 25.41%. The net profit attributable to shareholders was 91.1553 million yuan, up 62.13% year-on-year, with a non-recurring net profit of 88.2607 million yuan, increasing by 63.75% year-on-year. The company's debt ratio stands at 40.0% [1] - Qiaqia Food's Q1 2025 report shows a revenue of 1.571 billion yuan, a year-on-year decrease of 13.76%. The net profit attributable to shareholders was 77.2478 million yuan, down 67.88% year-on-year, with a non-recurring net profit of 58.0845 million yuan, decreasing by 73.76% year-on-year. The debt ratio is 40.23% [2] Group 2: Institutional Overview - Shanghai Licheng Asset is one of the earliest established private equity management companies in China, focusing on a growth stock investment philosophy with a margin of safety. The firm has developed a comprehensive investment management knowledge system over thirteen years [3] - The company has a workforce of 50 employees, with nearly 30 being professional research and investment personnel. The management scale has exceeded 10 billion yuan, specializing in secondary stock long strategies and PIPE strategies in the fields of pharmaceuticals, advanced manufacturing, and consumer goods [3] - Licheng has consistently ranked high in long-term performance and has received four private equity "Golden Bull" awards over three sessions [3]

Core Viewpoint - The company reported a significant decline in revenue and net profit for 2024, with ongoing challenges in its core business and a need for strategic adjustments to improve profitability [1][3]. Financial Performance - In 2024, the company achieved revenue of 278 million yuan, a year-on-year decrease of 20.92%, and a net profit attributable to shareholders of -57 million yuan, down 309.69% year-on-year [1]. - For Q1 2025, revenue was 63 million yuan, a decline of 7.18% year-on-year, with a net profit of 1.25 million yuan, down 77.89% year-on-year [1]. - The company's gross margin for 2024 was 21.9%, a decrease of 14.3 percentage points, with various expense ratios increasing due to expansion and credit impairment losses [3]. Business Segments - The bio-fermentation feed business generated revenue of 220 million yuan in 2024, a year-on-year increase of 10.19%, with sales volume rising by 20.74% to 112,600 tons [2]. - The inorganic waste treatment service business saw revenue drop to 40 million yuan, a decline of 71.52%, as the company opted not to take on new projects with long payment cycles [2]. - In Q1 2025, the bio-fermentation feed business revenue was 50 million yuan, down 7.38% year-on-year, while the inorganic waste treatment service revenue increased by 22.35% to 13 million yuan [2]. Capacity and Strategic Initiatives - The company has established five bio-fermentation feed factories with a total capacity of 470,000 tons per year, with plans to expand to 700,000 tons per year [4]. - Strategic investments from state-owned enterprises have improved the company's capital structure and financial stability, allowing for better market penetration and collaboration with large breeding groups [4]. - Future revenue projections for 2025-2027 are estimated at 390 million, 530 million, and 720 million yuan, respectively, with corresponding EPS of 0.01, 0.27, and 0.60 yuan [4].